Patient leaflet - HYPROMELLOSE EYE DROPS BP 0.3% W/V
HYPROMELLOSE 0.3%
Patient Information Leaflet
Please read this leaflet carefully before you start to take your medicine.
Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet.
-
1. What Hypromellose 0.3% w/v Eye Drops are and what they are used for
-
2. Before you use Hypromellose 0.3% w/v Eye Drops
-
3. How to use Hypromellose 0.3% w/v Eye Drops
-
4. Possible side effects
-
5. How to store Hypromellose 0.3% w/v Eye Drops
-
6. Further information
-
1. What Hypromellose 0.3% w/v Eye Drops are and what they are used for.
Hypromellose 0.3% w/v Eye Drops are a soothing emollient solution used as artificial tears. It may be used to help moisten hard contact lenses and to lubricate ocular prosthetics (artificial eyes). It prevents damage to the cornea when the ocular surface is not properly lubricated and covered by the eyelids. Hypromellose 0.3% w/v Eye Drops provides relief of dry eye conditions (including those associated with the use of VDUs and TVs, infrequent blinking, certain medical treatments, atmospheric pollution and drying atmospheres, e.g. air conditioning, central heating, wind and sun).
2. before you use hypromellose 0.3% w/v eye drops
Do not use Hypromellose 0.3% w/v Eye Drops:
- if you wear soft contact lenses because this medicine contains
benzalkonium chloride solution and it can react with soft contact lenses
- for children under three years.
- are allergic/sensitive to any of the ingredients in this product
- wear soft contact lenses. (Contains Benzalkonium Chloride)
- are pregnant or breast-feeding.
- are taking other medicines Hypromellose may increase the time other medicines stay in the eye.
Please tell your doctor, if you are using this medicine and develop signs of irritation or sensitivity.
Taking other medicines
Please tell your doctor or pharmacist if you are applying any other type of eye drops or eye ointment before you start to use this medicine. Your medicine may affect their action and could alter their effect.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without any prescription.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, you should discuss this with your doctor before you start to apply the eye drops.
Driving and using machines
Do not drive or operate machines if you have blurred vision after using Hypromellose 0.3% w/v Eye Drops. You should wait until this clears before driving or using machines.
Hypromellose 0.3% w/v Eye Drops contains benzalkonium chloride
This medicine contains 2.8 micrograms benzalkonium chloride in each drop which is equivalent to 0.1 mg/ml. Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and put them back 15 minutes afterwards.
Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.
3. how to use hypromellose 0.3% w/v eye drops
Always use Hypromellose 0.3% w/v Eye Drops exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
The dose depends upon the need for lubrication. Usually 1–2 drops should be administrated into each eye three times daily, or as directed by your doctor.
To help keep the contents sterile, do not allow the dropper to touch your eyelids, fingers or any other surface.
Throw away the unused contents of the bottle after 28 days from first opening it.
Overdose
There is no experience of an overdosage with Hypromellose Eye Drops which is unlikely when given as eyedrops. If you accidentally swallow them contact your doctor.
4. possible side effects
Like all medicines, Hypromellose 0.3% w/v Eye Drops can cause side effects, although not everybody gets them. Most of these side effects affect only the eye and may not last very long.
If you have any severe or persistent side effects, you should stop using the drops and contact your doctor immediately. Side effects include:
Blurred vision, eye pain, foreign body sensation in eyes, eye irritation, redness. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website at or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
5. how to store hypromellose 0.3% w/v eye drops
Keep out of the reach and sight of children.
Do not store at a temperature above 25°C.
Keep the container tightly closed.
Discard the bottle 28 days after opening, even if there is solution remaining.
Do not use Hypromellose 0.3% w/v Eye Drops after the expiry date which is stated on the bottle and on the carton the bottle is packed in.
-
6. Further information What Hypromellose 0.3% w/v Eye Drops contain
What Hypromellose 0.3% w/v Eye Drops look like and contents of the pack
One bottle of Hypromellose 0.3% w/v Eye Drops contains 10 ml solution.
Manufacturer
EXCELVISION
27, rue de la Lombardiere BP 131 07100 Annonay France
Marketing Authorisation Holder MEDICOM HEALTHCARE LTD LYNTON HOUSE, 7–12 TAVISTOCK SQUARE,
KINGS CROSS, LONDON,
WC1H 9LT,
UNITED KINGDOM
PL number 18956/0007
Hard to see or read the leaflet?
Call: +44 (0)1489 574119 or see website for help:
This leaflet was last revised in: 09/2020
1-HPMC-11-GB-PV5